跳至主要内容
临床试验/CTRI/2011/091/000182
CTRI/2011/091/000182已完成4 期

A randomized double blind parallel group comparative study to evaluate efficacy and safety of triplet combination (Ciclosonide, Tiotropium bromide and Formoterol) and dual combination (Tiotropium bromide and Formoterol) in mild to moderate cases of Chronic Obstructive Pulmonary Disease

Research project grant of Government of Gujarat0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age between 35 to 70 years of either sex
  • Clinically diagnosed mild to moderate COPD as per GOLD guideline (FEV1 more than 50 FEV1 and FVC ratio less than 0.7)
  • Ability to give written informed consent
  • Smokers and ex-smokers more and equal to 10 pack per years

排除标准

  • Patients on oral steroid
  • History Of significant illness of other system especially cardiovascular system
  • History of exacerbation in run in period
  • Patients having other serious respiratory illness ( tuberculosis asthma) other than COPD
  • History of long acting antihistaminic within 1 week
  • History of Hypersensitivity to study medications
  • Contraindication to six minute walk test
  • Do not give informed consent

研究者

发起方
Research project grant of Government of Gujarat

相似试验